Top compounds associated with response to PRDM16


Feature Type Standardized
Nominal ANOVA
mRNA SN-38 CTRPv2 pan-cancer AAC 0.073 0.05
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.064 0.05
mRNA PD173074 GDSC1000 pan-cancer AAC 0.067 0.05
mRNA AC220 GDSC1000 pan-cancer AAC 0.066 0.05
mRNA BHG712 GDSC1000 pan-cancer AAC 0.056 0.05
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.06 0.06
mRNA foretinib GDSC1000 pan-cancer AAC 0.06 0.06
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.066 0.06
mRNA thalidomide CTRPv2 pan-cancer AAC 0.11 0.06
mRNA CHIR-99021 CTRPv2 pan-cancer AAC -0.063 0.06
Download CSV